MJardin Enters into Definitive Agreement for the Sale of its Cheyenne Cultivation Facility
02 Januar 2020 - 2:00PM
MJardin Group, Inc. (“MJardin” or the “Company”) (CSE: MJAR)
(OTCQX: MJARF), a leader in premium cannabis production, announced
today that it has entered into a definitive agreement with Harvest
DCP of Nevada, Cheyenne Holdings LLC, a division of Harvest Health
and Recreation Inc. (CSE:HARV) to sell all of its interest in
GreenMart of Nevada LLC, which possesses a Nevada Marijuana
Cultivation Facility License and operates the cultivation facility
at 5421 E. Cheyenne, Nevada, (“Cheyenne”) for a total consideration
of US$35 million in cash, comprised of US$30 million on December
31, 2019, plus US$5 million upon license transfer (the
“Transaction”), subject to regulatory approvals.
The Company will use the proceeds of the
transaction to reduce its debt obligations and for working capital
requirements for its 2020 plan.
“We are pleased with the return on our investment
at Cheyenne. The proceeds from the Transaction significantly reduce
our debt while strengthening our financial position towards funding
our working capital requirements in 2020,” said Pat Witcher,
President and CEO of MJardin. “We are starting the new year on
stronger footing with a clear view on accomplishing our
profitability targets based on all of our key assets coming
online.”
MJardin continues to focus on growing operations in
Nevada through Cannabella, an extraction, distribution and consumer
product company acquired in the Spring of 2019 (license transfer
pending). Cannabella’s products are already in approximately 50 of
the 68 retail dispensaries in Nevada, and the Company anticipates
that it will be able to expand to many of the new dispensaries
being opened following the recent grant of approximately 50
additional licenses.
The Transaction has been unanimously approved by
the Board of Directors of the Company, following the unanimous
recommendation of a special committee of independent directors of
the Company. Canaccord Genuity Corp. (“Canaccord Genuity”) acted as
exclusive financial advisor to MJardin. Canaccord Genuity and
Cormark Securities have provided fairness opinions to the special
committee of the Board of Directors of the Company stating that, as
of the date of such opinions, and based upon and subject to the
assumptions, limitations and qualifications stated in such
opinions, the consideration being received under the Transaction is
fair, from a financial point of view, to the Company. Foley &
Lardner LLP acted as U.S. counsel and Norton Rose Fulbright Canada
LLP acted as Canadian counsel to MJardin on the Transaction.
About MJardin GroupMJardin is a
cannabis management platform with extensive experience in
cultivation, processing, distribution and retail. For over 10
years, MJardin has refined cultivation methodologies, developed
state of the art facilities and implemented vertical integration
for and on behalf of license owners. MJardin is based in Denver,
Colorado and Toronto, Canada. For more information, please visit
www.mjardin.com.
The CSE has not in any way passed upon the merits
of and has neither approved nor disapproved the contents of this
news release.
This news release does not constitute an offer to
sell or a solicitation of an offer to sell any of the securities in
the United States. The securities have not been and will not be
registered under the United States Securities Act of 1933, as
amended (the “U.S. Securities Act”) or any state securities laws
and may not be offered or sold within the United States or to U.S.
Persons unless registered under the U.S. Securities Act and
applicable state securities laws or an exemption from such
registration is available.
Forward-Looking InformationThis
news release contains forward-looking information based on current
expectations. Statements about, among other things, future
developments and the business and operations of MJardin, our
production capacity, our production results, trading of MJardin’s
shares on the OTCQX Best Market, the receipt of any pending
regulatory approvals or licenses, the growth of our global
footprint and our intentions to leverage our scale for continued
organic growth and to pursue strategic investments are all
forward-looking information. These statements should not be read as
guarantees of future performance or results. Such statements
involve known and unknown risks, uncertainties and other factors
that may cause actual results, performance or achievements to be
materially different from those implied by such statements. Such
factors include, but are not limited to: our ability to identify
and pursue growth, financing and other strategic objectives, and
the regulatory and economic environments in the jurisdictions we
operate or intend to operate or investment in. Although such
statements are based on management’s reasonable assumptions at the
date such statements are made, there can be no assurance that the
proposed acquisition will occur and that such forward-looking
information will prove to be accurate, as actual results and future
events could differ materially from those anticipated in such
forward-looking information. Accordingly, readers should not place
undue reliance on the forward-looking information. MJardin assumes
no responsibility to update or revise forward-looking information
to reflect new events or circumstances unless required by
applicable law.
INVESTOR CONTACT: Ali
Mahdavi
Capital Markets & Investor
Relations
416-962-3300
Ali.mahdavi@MJardin.com
Pat
Witcher
CEO
Pat.Witcher@MJardin.com
Harvest Health & Recreat... (CSE:HARV)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Harvest Health & Recreat... (CSE:HARV)
Historical Stock Chart
Von Dez 2023 bis Dez 2024